Role of myocardial revascularization in sudden cardiac death

Area of Science:

• Cardiology
• Cardiac Electrophysiology
• Cardiovascular Surgery

Background:

• Extensive atherosclerotic coronary artery disease is the most common finding in sudden cardiac death (SCD) cases.
• Acute myocardial ischemia frequently contributes to SCD.
• Interventions like beta-blockers and coronary artery bypass grafting (CABG) reduce cardiac mortality in specific patient groups.

Purpose of the Study:

• To outline therapeutic management strategies for patients at risk of sudden cardiac death.
• To evaluate the role of myocardial revascularization and electrophysiological testing in guiding treatment.
• To assess the effectiveness of interventions in preventing life-threatening arrhythmias.

Main Methods:

• Review of clinical trial data and therapeutic management principles.
• Analysis of factors influencing treatment decisions, including coronary artery disease extent, ventricular function, and inducible arrhythmias.
• Electrophysiological testing to assess inducibility of ventricular arrhythmias.

Main Results:

• Myocardial revascularization is primary for critical stenosis with at-risk myocardium and no inducible arrhythmias.
• Postoperative testing is crucial for patients with inducible polymorphic ventricular tachycardia/fibrillation, as surgery alone suppresses it in only 50%.
• Surgical revascularization alone is often insufficient for inducible sustained monomorphic ventricular tachycardia with myocardial infarction scars.

Conclusions:

• Therapeutic decisions for SCD survivors must integrate coronary artery disease assessment, ventricular function, and electrophysiological findings.
• Coronary artery surgery alone may not suffice for certain inducible arrhythmias; further antiarrhythmic strategies are necessary.
• Percutaneous transluminal coronary angioplasty lacks evidence as sole therapy for post-SCD patients with inducible ventricular tachycardia/fibrillation.